Nabla Bio

Nabla Bio

Verified
4.0
9 saves
Updated November 13, 2026

Lab-tested AI protein design for biopharma teams pursuing hard-to-drug targets.

Key Takeaways

What it is
Lab-tested AI protein design for biopharma teams pursuing hard-to-drug targets.
Best for
  • JAM generative molecular design
  • Epitope-specific antibody design
  • Multispecific design
Rating
4.0/5

What is Nabla Bio?

Nabla Bio’s JAM system designs proteins such as antibodies from a disease target or a specific target site, then pairs those designs with experimental testing. The company works with pharmaceutical partners seeking new biologic medicines, especially when traditional discovery methods struggle to find molecules with the desired binding and drug-like properties.

Nabla combines generative protein design with its own human-relevant testing, measuring whether designed molecules bind, behave well, and function in cellular and in vivo settings. For partners, that connects AI-generated designs to experimental evidence rather than leaving them as computer-generated proposals.

Nabla is best suited to biopharma teams with a defined drug-discovery program and the expertise to advance biologic candidates. It describes access through partnerships and licensing, not a public self-serve product, and it does not disclose JAM’s full methods; think of it as a potential discovery partner, not a downloadable AI tool.

Who is Using Nabla Bio?

Computational biologists

Their modeling and data work can help turn target and experimental information into new molecular designs.

Antibody engineers

Epitope-specific designs give them candidates to evaluate for binding and desired function.

Protein scientists

Experimental measurements help assess whether designed proteins have useful developability properties.

Drug discovery leaders

Parallel design campaigns can support decisions about which biologic targets and programs to pursue.

Uncommon Use Cases

Exploring antibodies against hard-to-reach GPCR sites; designing multispecific molecules that engage multiple disease pathways.

Key Features

JAM generative molecular design: JAM uses a target or other partial molecular context to generate proposed biologic designs.
Epitope-specific antibody design: Design campaigns can target different chosen sites on a protein, helping teams explore how those sites affect function.
Multispecific design: Starting from validated binding components, JAM proposes multispecific molecules intended to retain binding and developability.
Human-relevant experimental testing: Nabla measures binding, developability, and function using its experimental systems.
Parallel antibody campaigns: Multiple target campaigns can run in parallel, including work on difficult targets such as GPCRs.

Rating Breakdown

4.0/ 5.0
accuracy
4.3
ease of use
3.5
features
4.6
speed
4.2
support
3.7
value
3.7

Pricing Plans

Customized Solutions

  • Nabla Bio offers bespoke pricing depending on the scope and scale of the partnership

Enterprise Agreements

  • Typically involves comprehensive contracts with pharmaceutical companies for full platform access and collaboration

Nabla Bio Use Cases

Antibody discovery across target sites

A discovery team can compare designs aimed at distinct sites on a disease target to explore differences in function.

Outcome: Candidate antibodies and experimental measurements for selected target sites.

Multispecific biologic design

When validated binding components are available, JAM can propose architectures that link them into one molecule.

Outcome: Proposed multispecific designs intended to retain binding and developability.

Hard-to-drug target exploration

For targets such as GPCRs, design campaigns can focus on specific binding sites and test selectivity and function.

Outcome: Designed candidates assessed with Nabla’s human-relevant assays.

Biologic molecule licensing

A partner with development expertise can license a Nabla-designed molecule for further development.

Outcome: Access to selected designed biologics for partner-led development.

Workflow Ideas with Nabla Bio

Target-to-antibody campaign

  1. 1Choose a disease target or specific site on the target.
  2. 2Run a JAM campaign to generate antibody designs.
  3. 3Measure binding, developability, and function with experimental testing.

Multispecific concept evaluation

  1. 1Start with validated binding components.
  2. 2Generate proposed multispecific architectures.
  3. 3Assess whether designs retain binding and show suitable developability.

Hard-target exploration

  1. 1Select a difficult target such as a GPCR, ion channel, or transporter.
  2. 2Design antibodies against chosen target sites.
  3. 3Measure selectivity and function in relevant assays.

How Nabla Bio fits into your stack

Biologic discovery

Nabla’s platform is designed to sit within pharmaceutical discovery pipelines, generating antibody and other biologic candidates.

Experimental validation

Its wet-lab systems measure binding, developability, and function to evaluate generated designs.

Partner development

Pharma partnerships embed the platform in discovery programs, while licensing lets partners advance selected molecules.

Pros

  • +Design plus testing: Generated molecules are evaluated with experimental measurements, not only computer predictions.
  • +Chosen binding sites: Epitope-specific design can help teams compare antibody activity across different target sites.
  • +Difficult targets: The platform is built to pursue challenging targets, including GPCRs, ion channels, and transporters.
  • +More than antibodies: Nabla describes design work spanning multispecifics and other custom biologics.

Cons

  • −Partner-led access: The public site describes collaborations and licensing rather than a self-serve product.
  • −Limited method transparency: Nabla says it does not disclose some JAM methodological details for commercial reasons.

Limitations & when to consider alternatives

Known limitations

  • JAM methods are not fully disclosed. Nabla states that it withholds some methodological details for commercial reasons.
  • No published self-serve pricing. The public site describes partnership and licensing inquiries but does not list standard prices.

Look elsewhere when

  • You need a self-serve protein-design app with public signup and published pricing.
  • Your team needs a developer API or downloadable software that Nabla documents publicly.

How to Use Nabla Bio

  1. 1

    Choose a partnership route

    Decide whether you want to discuss using the platform in a discovery pipeline or licensing a designed molecule.

  2. 2

    Contact the business development team

    Nabla directs partnership and licensing inquiries to [email protected].

  3. 3

    Scope the discovery program

    For a platform partnership, discuss the biologic target or program you want to advance and how the platform could fit into your pipeline.

  4. 4

    Discuss candidate development

    For licensing, identify the designed molecule or disease target of interest and discuss next steps with Nabla.

Who is Nabla Bio For?

Pharmaceutical companies

Partners can bring Nabla’s design and testing platform into biologic discovery programs.

Biologics discovery teams

Teams working on antibodies or multispecifics can explore designs with selected target properties.

Teams pursuing difficult targets

The platform is aimed at targets that are difficult to address with conventional discovery methods.

Biopharma companies seeking molecule licenses

Nabla also licenses designed biologics to partners with drug-development expertise.

Frequently Asked Questions

What does Nabla Bio do?

It combines AI-based biologic design with experimental testing, and works with pharmaceutical partners on discovery programs and molecule licensing.

Can anyone sign up and use JAM?

Nabla’s public site describes platform partnerships and licensing, not an open self-serve signup.

How much does Nabla Bio cost?

The public site does not list standard prices. Contact Nabla to discuss partnership or licensing terms.

What kinds of molecules does Nabla design?

Nabla describes work on antibodies, multispecifics, and other custom biologics.

Does Nabla provide experimental testing?

Yes. Its platform includes experimental systems that measure binding, developability, and function.

Community reviews

Be the first to share your experience.

Sign in to leave a review for Nabla Bio.

No reviews yet. Yours could be the first.

Nabla Bio Alternatives

Looking for alternatives to Nabla Bio? Here are similar tools in the same category:

Nabla Bio screenshot
Contact for Pricing